Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

[Contribution of in vitro models to the management of hematologic risk in pharmacovigilance].

Carlhant D, de Tailly PD, Vignot JL, Riché C, Léglise MC.

Therapie. 1996 Sep-Oct;51(5):489-99. French.

PMID:
9138382
2.

Modified in vitro conditions for cord blood-derived long-term culture-initiating cells.

Podestà M, Piaggio G, Pitto A, Zocchi E, Soracco M, Frassoni F, Luchetti S, Painelli E, Bacigalupo A.

Exp Hematol. 2001 Mar;29(3):309-14.

PMID:
11274758
3.

Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors "in vitro": comparison between species and sexes.

Ferrario D, Croera C, Brustio R, Collotta A, Bowe G, Vahter M, Gribaldo L.

Toxicology. 2008 Jul 30;249(2-3):102-8. doi: 10.1016/j.tox.2008.04.008. Epub 2008 Apr 22.

PMID:
18524450
4.
5.
6.

A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.

Kiss J, Kunstár A, Fajka-Boja R, Dudics V, Tóvári J, Légrádi A, Monostori E, Uher F.

Exp Hematol. 2007 Feb;35(2):305-13.

PMID:
17258079
7.

Use of in vitro assays to assess hematotoxic effects of environmental compounds.

Van Den Heuvel RL, Leppens H, Schoeters GE.

Cell Biol Toxicol. 2001;17(2):107-16.

PMID:
11499694
8.
9.

Megakaryocytopoiesis in vitro: from the stem cells' perspective.

Cardier JE, Foster DC, Lok S, Jacobsen SE, Murphy MJ Jr.

Stem Cells. 1996;14 Suppl 1:163-72.

11.
12.

In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.

Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, Leteurtre F, Coulombel L, Douay L.

Exp Hematol. 2000 Dec;28(12):1470-80.

PMID:
11146169
13.

[Effects of murine bone marrow endothelial cells on the in vitro expansion of human cord blood hematopoietic progenitor cells].

Wang JH, Cheng LM, Ma LX.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Apr;29(2):135-8. Chinese.

14.

Effect of angiotensin II on hematopoietic progenitor cell proliferation.

Rodgers KE, Xiong S, Steer R, diZerega GS.

Stem Cells. 2000;18(4):287-94.

15.
16.

Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia.

Wodnar-Filipowicz A, Chklovskaia E, Manz CY, Lyman SD, Nissen C.

Exp Hematol. 1997 Jul;25(7):573-81.

PMID:
9216732
17.

Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.

Möbest D, Goan SR, Junghahn I, Winkler J, Fichtner I, Hermann M, Becker M, de Lima-Hahn E, Henschler R.

Stem Cells. 1999;17(3):152-61.

18.
19.

Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.

Horowitz D, Callahan JF, Pelus LM, Fukuda S, King AG.

Int Immunopharmacol. 2002 Apr;2(5):721-30.

PMID:
12013510
20.

[Umbilical cord blood as a source of stem cells].

Bojanić I, Golubić Cepulić B.

Acta Med Croatica. 2006 Jun;60(3):215-25. Review. Croatian.

PMID:
16933834

Supplemental Content

Support Center